Preimplantation Genetic Testing for Monogenic or Single Gene Disorders (PGT-M) is a revolutionary technology offering hope to couples with a family history of serious inherited conditions. These conditions result from mutations in a single gene, which can be inherited from one or both parents. PGT-M enables the selection of embryos without the disease-causing mutation before implantation into the woman's womb, thus giving couples the chance to start a family without the fear of passing on the genetic condition to the next generation.
This type of embryo testing can diagnose common single gene disorders such as Thalassemia, Haemophilia A and B etc. For couples who are carriers of these genetic disorders, PGT-M offers a solution and the possibility of having healthy children, also eliminating the difficult decision of terminating a pregnancy due to a genetic condition. PGT-M is a groundbreaking advancement in reproductive technology, providing a brighter future for couples with inherited genetic disorders.